Frontline Ltd (FRO) 7.39 $FRO 4 Growth Dividend Stocks

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Frontline Ltd (FRO) 7.39 $FRO

4 Growth Dividend Stocks While Markets Choose Direction
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 10:33AM CDT
4 stock picks with good growth and high dividends.
FRO: 7.39 (-0.29), BBY: 32.78 (-0.69), NEWM: 17.20 (-0.52), SPKE: 24.42 (-0.13)

The Zacks Analyst Blog Highlights: Altria Group, Intel, Frontline, Grupo Aeroportuario del Centro Norte, S.A.B. de C.V. and Enbridge
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 8:30AM CDT
The Zacks Analyst Blog Highlights: Altria Group, Intel, Frontline, Grupo Aeroportuario del Centro Norte, S.A.B. de C.V. and Enbridge
FRO: 7.39 (-0.29), ENB: 40.27 (+0.26), MO: 67.42 (-0.23), INTC: 34.39 (-0.46), OMAB: 48.73 (-0.15)

FRO - 2016 Annual General Meeting
GlobeNewswire - Wed Jul 13, 1:35AM CDT
Frontline Ltd. advises that its 2016 Annual General Meeting will be held on September 23, 2016. The record date for voting at the Annual General Meeting is set to July 25, 2016. The notice, agenda and associated material will be distributed prior to the meeting.
FRO: 7.39 (-0.29)

5 Stocks with Impressive Growth Prospects and Yields
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 11:08AM CDT
Here are the five stocks that follow the 'holy grail' of dividend-growth investing and offer tremendous growth potential, high-dividend yield and consistent and safe operations
PM: 99.92 (-0.23), FRO: 7.39 (-0.29), ENB: 40.27 (+0.26), MO: 67.42 (-0.23), INTC: 34.39 (-0.46), OMAB: 48.73 (-0.15)

FRO - Grant of share options to members of the Board of Directors and management
GlobeNewswire - Wed Jul 06, 1:23AM CDT
Frontline Ltd. ("Frontline" or the "Company" hereby announces that 1,170,000 share options have been awarded to employees and board members in accordance with the terms of the Company's Share Option Scheme. The share options will have a five-year term and will vest equally one third over a three-year vesting period. The exercise price is USD 8.00. The exercise price will be adjusted for any distribution of dividends made before the relevant options are exercised.
FRO: 7.39 (-0.29)

FRO - Sale of six medium range tankers
GlobeNewswire - Mon Jun 13, 6:30AM CDT
Frontline Ltd. (the "Company" or "Frontline" (NYSE:FRO - OSE:FRO) today announced that it has entered into an agreement whereby the Company will sell its six medium range tankers for an aggregate sale price of $172.5 million to an unaffiliated third party. The vessels will be delivered by Frontline during September and October 2016.
FRO: 7.39 (-0.29)

FRO - Acquisition of VLCC newbuilding contracts
GlobeNewswire - Thu Jun 09, 4:23PM CDT
Frontline Ltd. (the "Company" or "Frontline" (NYSE:FRO) is pleased to announce the acquisition of two VLCC newbuildings under construction at Hyundai Heavy Industries at a purchase price of $84 million each. The vessels are due for delivery in September and November 2016.
FRO: 7.39 (-0.29)

Why Investors Love These Shipping's Stocks? - Nordic American Tankers, Frontline, GasLog, and Ultrapetrol
PR Newswire - Thu Jun 09, 7:15AM CDT
After facing rough waters the previous year, the Shipping industry is now steadily heading toward calmer seas, making stocks in this space an interesting observation. This morning, ActiveWallSt.com steers investors' attention back to Nordic American Tankers Ltd (NYSE: NAT), Frontline Ltd (NYSE: FRO), GasLog Ltd (NYSE: GLOG), and Ultrapetrol (NASDAQ: ULTR). Learn more about these stocks and access their free alerts by clicking below:
GLOG: 12.35 (-0.61), FRO: 7.39 (-0.29), NAT: 11.66 (-0.54), ULTR: 0.32 (+0.01)

This Week's Top Value Stocks: (ASGN)(FRO)
Tracey Ryniec - Zacks Investment Research - Thu Jun 02, 2:56PM CDT
Tracey Ryniec is back, and she gives us two value stocks!
FRO: 7.39 (-0.29), ASGN: 35.75 (-0.94)

FRO - Frontline, Diamond S. Shipping and Euronav join in formation of Suezmax Chartering
GlobeNewswire - Thu Jun 02, 10:52AM CDT
Frontline Ltd. ("Frontline", today announces the formation of Suezmax Chartering, a commercial joint venture with Diamond S. Shipping LLC and Euronav NV. The aim of the joint venture is to create a single point of contact for cargo owners to access a large fleet of 43 modern Suezmax vessels, traded operated on the spot market. Frontline will contribute 22 vessels to the joint venture, including 14 vessels on the water and 8 newbuildings as they are delivered.
FRO: 7.39 (-0.29)

FRO - Q1 2016 Presentation
GlobeNewswire - Tue May 31, 7:10AM CDT
Please find enclosed the presentation of Frontline Ltd.'s first quarter 2016 results.
FRO: 7.39 (-0.29)

FRONTLINE LTD. REPORTS RESULTS FOR THE FIRST QUARTER 2016
GlobeNewswire - Tue May 31, 1:57AM CDT
Frontline Ltd. (the "Company" or "Frontline", today reported unaudited results for the three months ended March 31, 2016:
FRO: 7.39 (-0.29)

What's in the Cards for Medtronic (MDT) in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Thu May 26, 6:22AM CDT
Medtronic plc (MDT) is slated to report its fourth-quarter and fiscal 2016 earnings on May 31.
SCCO: 25.74 (+0.32), FRO: 7.39 (-0.29), MDT: 87.49 (-0.57), BNS: 49.96 (unch)

FRO - Invitation to Q1 2016 Results Conference Call and Webcast
GlobeNewswire - Wed May 25, 3:04AM CDT
Frontline Ltd.'s preliminary first quarter 2016 results will be released on Tuesday May 31, 2016 and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m U.S. Eastern Time). The results presentation will be available for download from the Investor Relation section at www.frontline.bm ahead of the conference call.
FRO: 7.39 (-0.29)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CICYBELL's Black Friday Is a Fashionist's Dream

Updated Category News Views 34

Stepping Into the Fashion Frenzy It’s that time of year again, where shoppers are girding up for Black Friday. And here comes CICYBELL, ready to dish up some meaty discounts that would turn even the most hardened cynic into a frenzied shopper. Alright, maybe that’s a touch dramatic, but let’s break down what this fashion brand is cooking up in their latest sale....

Continue Reading
Horizon Capital Hits €200M for Ukraine Resilience

Updated Category News Views 37

An Unprecedented Leap Amidst Uncertainty Right in the middle of rebuilding a nation, Horizon Capital's Catalyst Fund has managed to tap into a well of optimism—or guts, depending on how you look at it. With €200 million already in its pocket out of a €300 million goal, this private equity powerhouse is taking a calculated gamble on Ukraine's economic resilience and...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 184

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
MatterSeek Platform Revolutionizing Materials R&D Worldwide

Updated Category News Views 39

Innovating the R&D Landscape with MatterSeek In the ever-changing realm of materials research and development, Yuyao Technology's latest innovation, MatterSeek, is a game changer. It's a slick launch, folks, redefining how we look at the R&D landscape through its AI-driven abilities. This ain't just another pie-in-the-sky platform; it's an actual workhorse designed to...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 122

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 280

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Bank Hapoalim's Q3 2026: Steady Growth Amid Challenges

Updated Category News Views 22

Digging Deep into Hapoalim's Recent Results Now ain't this a turn of events? Bank Hapoalim rolls out its numbers for Q3 2026, and while there's no confetti dropping from the ceiling, the numbers are telling their own story. Net profit comes to a solid NIS 2,364 million, but we're looking at a landscape that's not all rose-tinted today. The bank's managed to pull off...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 75

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 111

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

Luckbox Stock Reaches New Low: Market Movements Explained

Updated Category News Views 326

Luckbox Stock Performance Overview The gaming and esports betting company, Luckbox, is currently navigating a fluctuating market landscape, with its stock price recently dipping to a notable 52-week low of $9.68. This shift is a pronounced departure from the previous year, reflecting ongoing challenges within the industry. As of now, the company's market capitalization...

Continue Reading
Nota AI and Renesas: Revolutionizing Driver Monitoring Technology

Updated Category News Views 153

Collaboration Between Nota AI and Renesas Nota AI, known for its expertise in AI optimization, has announced an exciting partnership with Renesas Electronics Corporation, aiming to advance driver monitoring technology through the optimized Driver Monitoring System (DMS). This collaboration is particularly focused on the new RA8P1 microcontroller unit (MCU), which is...

Continue Reading
Mirum Pharmaceuticals Presents Promising LIVMARLI Data at Conference

Updated Category News Views 107

Mirum Pharmaceuticals showcases LIVMARLI research findings Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has announced its participation in a significant scientific meeting where it aims to present groundbreaking data on LIVMARLI® (maralixibat) oral solution. This event is hosted by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition...

Continue Reading
Genmab Stock Faces Challenges, Yet Holds Hope for Recovery

Updated Category News Views 130

Genmab Stock Overview Genmab A/S Sponsored ADR (NASDAQ: GMAB) has recently experienced a turbulent period, with a notable decline of 14.7% in just four weeks. However, this decline has left the stock in an oversold position, igniting hope among investors as analysts anticipate improved earnings results. Understanding Oversold Conditions To assess whether a stock, such as...

Continue Reading
Challenges Ahead for Central Banks Tackling Inflation Variability

Updated Category News Views 117

Challenges Ahead for Central Banks in Addressing Inflation Fluctuations Inflation is a complex issue for policymakers, as recent comments from European Central Bank President Christine Lagarde illustrate. With substantial changes happening in the global economy, the prospect of stable inflation remains uncertain. Lagarde suggests that inflation may experience significant...

Continue Reading